Stockreport

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

ProMIS Neurosciences Inc. - Common Shares  (PMN) 
PDF Cambridge, Massachusetts, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation [Read more]